In patients with subclinical hypothyroidism, the presence of thyroperoxidase (TPO) antibodies predicts a higher risk of developing overt hypothyroidism, 4.3% per year versus 2.1% per year in antibody-negative individuals.
TPO antibodies in hypothyroidism
- Post author:
- Post published:June 11, 2021
- Post category:Uncategorized
- Post comments:0 Comments